Search

Leah H. Schlientz

Examiner (ID: 5396)

Most Active Art Unit
1618
Art Unit(s)
1618
Total Applications
804
Issued Applications
283
Pending Applications
116
Abandoned Applications
429

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18019142 [patent_doc_number] => 20220370641 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-24 [patent_title] => SILICONE-BASED DYES WITH SHORT WAVELENGTH INFRARED ABSORPTION AND EMISSION AND METHODS FOR MAKING AND USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/662574 [patent_app_country] => US [patent_app_date] => 2022-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12050 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17662574 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/662574
Silicone-based dyes with short wavelength infrared absorption and emission and methods for making and using the same May 8, 2022 Issued
Array ( [id] => 18275512 [patent_doc_number] => 11614451 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-03-28 [patent_title] => Targeting ligands for tau pathology [patent_app_type] => utility [patent_app_number] => 17/739031 [patent_app_country] => US [patent_app_date] => 2022-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 16103 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17739031 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/739031
Targeting ligands for tau pathology May 5, 2022 Issued
Array ( [id] => 18075975 [patent_doc_number] => 20220401587 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-12-22 [patent_title] => LOW X-RAY ATTENUATION CHANGE HARD SHELLED ORAL CONTRAST MATERIAL [patent_app_type] => utility [patent_app_number] => 17/736957 [patent_app_country] => US [patent_app_date] => 2022-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15775 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17736957 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/736957
LOW X-RAY ATTENUATION CHANGE HARD SHELLED ORAL CONTRAST MATERIAL May 3, 2022 Abandoned
Array ( [id] => 19263764 [patent_doc_number] => 20240207461 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-06-27 [patent_title] => RADIOACTIVE ANTITUMOR AGENT [patent_app_type] => utility [patent_app_number] => 18/556577 [patent_app_country] => US [patent_app_date] => 2022-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21411 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18556577 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/556577
RADIOACTIVE ANTITUMOR AGENT Apr 20, 2022 Pending
Array ( [id] => 17988936 [patent_doc_number] => 20220354973 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-11-10 [patent_title] => IRON NITRIDE NANOPARTICLE SUSPENSION [patent_app_type] => utility [patent_app_number] => 17/659953 [patent_app_country] => US [patent_app_date] => 2022-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8082 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17659953 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/659953
IRON NITRIDE NANOPARTICLE SUSPENSION Apr 19, 2022 Pending
Array ( [id] => 19297778 [patent_doc_number] => 20240226344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => NUCLEIC ACID ORIGAMI PLATFORMS AND THEIR USES [patent_app_type] => utility [patent_app_number] => 18/286003 [patent_app_country] => US [patent_app_date] => 2022-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22699 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18286003 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/286003
NUCLEIC ACID ORIGAMI PLATFORMS AND THEIR USES Apr 11, 2022 Pending
Array ( [id] => 17881237 [patent_doc_number] => 20220296714 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-22 [patent_title] => TARGETED NANO-PHOTOMEDICINES FOR PHOTODYNAMIC THERAPY OF CANCER [patent_app_type] => utility [patent_app_number] => 17/714251 [patent_app_country] => US [patent_app_date] => 2022-04-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10018 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17714251 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/714251
TARGETED NANO-PHOTOMEDICINES FOR PHOTODYNAMIC THERAPY OF CANCER Apr 5, 2022 Abandoned
Array ( [id] => 17733366 [patent_doc_number] => 20220218825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => SURFACTANT MICROBUBBLES AND PROCESS FOR PREPARING AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 17/657028 [patent_app_country] => US [patent_app_date] => 2022-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5875 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17657028 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/657028
SURFACTANT MICROBUBBLES AND PROCESS FOR PREPARING AND METHODS OF USING THE SAME Mar 28, 2022 Abandoned
Array ( [id] => 19299955 [patent_doc_number] => 20240228524 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-07-11 [patent_title] => IRON(III) MACROCYCLIC COMPLEXES WITH MIXED HYROXYL PENDANTS AS MRI CONTRAST AGENTS [patent_app_type] => utility [patent_app_number] => 18/551458 [patent_app_country] => US [patent_app_date] => 2022-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22214 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -30 [patent_words_short_claim] => 155 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18551458 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/551458
IRON(III) MACROCYCLIC COMPLEXES WITH MIXED HYROXYL PENDANTS AS MRI CONTRAST AGENTS Mar 20, 2022 Pending
Array ( [id] => 17702957 [patent_doc_number] => 20220202963 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => RADIOLABELED COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/692632 [patent_app_country] => US [patent_app_date] => 2022-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12927 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17692632 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/692632
RADIOLABELED COMPOUNDS Mar 10, 2022 Abandoned
Array ( [id] => 17850393 [patent_doc_number] => 20220280434 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-08 [patent_title] => RAPIDLY DISINTEGRATING GELATINOUS COATED TABLETS [patent_app_type] => utility [patent_app_number] => 17/686962 [patent_app_country] => US [patent_app_date] => 2022-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10077 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17686962 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/686962
RAPIDLY DISINTEGRATING GELATINOUS COATED TABLETS Mar 3, 2022 Abandoned
Array ( [id] => 19104694 [patent_doc_number] => 11957767 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-04-16 [patent_title] => Compound targeting prostate specific membrane antigen, and preparation method and application thereof [patent_app_type] => utility [patent_app_number] => 18/548546 [patent_app_country] => US [patent_app_date] => 2022-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 15 [patent_no_of_words] => 5553 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18548546 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/548546
Compound targeting prostate specific membrane antigen, and preparation method and application thereof Feb 26, 2022 Issued
Array ( [id] => 19338580 [patent_doc_number] => 12048751 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-30 [patent_title] => Compositions and methods for assessing gut function [patent_app_type] => utility [patent_app_number] => 17/652037 [patent_app_country] => US [patent_app_date] => 2022-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6379 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17652037 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/652037
Compositions and methods for assessing gut function Feb 21, 2022 Issued
Array ( [id] => 17944458 [patent_doc_number] => 20220331475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-10-20 [patent_title] => Two Component Sealing Systems Including Synthetic Matrices and Biosynthetic Adhesives [patent_app_type] => utility [patent_app_number] => 17/667787 [patent_app_country] => US [patent_app_date] => 2022-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3483 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17667787 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/667787
Two Component Sealing Systems Including Synthetic Matrices and Biosynthetic Adhesives Feb 8, 2022 Pending
Array ( [id] => 18536167 [patent_doc_number] => 20230241255 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-08-03 [patent_title] => MAGNETIC RESONANCE CONTRAST AGENTS AND METHODS THEREOF [patent_app_type] => utility [patent_app_number] => 17/588458 [patent_app_country] => US [patent_app_date] => 2022-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10542 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17588458 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/588458
MAGNETIC RESONANCE CONTRAST AGENTS AND METHODS THEREOF Jan 30, 2022 Pending
Array ( [id] => 17593653 [patent_doc_number] => 20220143226 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => USE OF TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES [patent_app_type] => utility [patent_app_number] => 17/582283 [patent_app_country] => US [patent_app_date] => 2022-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9777 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17582283 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/582283
USE OF TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES Jan 23, 2022 Pending
Array ( [id] => 17733391 [patent_doc_number] => 20220218850 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-14 [patent_title] => Methods and Compositions for Two-Stage Microbubble Delivery of Active Agents [patent_app_type] => utility [patent_app_number] => 17/574790 [patent_app_country] => US [patent_app_date] => 2022-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29757 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17574790 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/574790
Methods and Compositions for Two-Stage Microbubble Delivery of Active Agents Jan 12, 2022 Pending
Array ( [id] => 19201543 [patent_doc_number] => 20240173442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-05-30 [patent_title] => COMBINATION THERAPY [patent_app_type] => utility [patent_app_number] => 18/271928 [patent_app_country] => US [patent_app_date] => 2022-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 70964 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18271928 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/271928
COMBINATION THERAPY Jan 10, 2022 Pending
Array ( [id] => 20534526 [patent_doc_number] => 12551577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-02-17 [patent_title] => 7-ethyl-10-hydroxycamptothecin drug precursor with fluorescence activity, and preparation method and use thereof [patent_app_type] => utility [patent_app_number] => 17/927722 [patent_app_country] => US [patent_app_date] => 2021-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 0 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17927722 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/927722
7-ethyl-10-hydroxycamptothecin drug precursor with fluorescence activity, and preparation method and use thereof Dec 29, 2021 Issued
Array ( [id] => 17519359 [patent_doc_number] => 20220105207 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-07 [patent_title] => Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer [patent_app_type] => utility [patent_app_number] => 17/552984 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7437 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552984 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/552984
Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer Dec 15, 2021 Abandoned
Menu